Literature DB >> 21960105

[Involvement of splenic hemangioma and rectal varices in a patient with klippel: trenaunay syndrome].

Youn Jung Choi1, Sam Ryong Jee, Kwan Sik Park, Choong Heon Ryu, Hyo Rim Seo, Seoung In Ha, Sang Heon Lee, Kyung Sun Ok.   

Abstract

Klippel - Trenaunay syndrome (KTS) is characterized by a cutaneous vascular nevus of the involved extremity, bone and soft tissue hypertrophy of the extremity and venous malformations. We present a case of KTS with splenic hemangiomas and rectal varices. A 29-year-old woman was referred for intermittent hematochezia for several years. She had history with a number of operations for cutaneous and soft tissue hamangiomas since the age of one year old and for increased circumference of her left thigh during the last few months. Abdominal CT revealed multiple hemangiomas in the spleen, fusiform aneurysmal dilatation of the deep veins and soft tissue hemangiomas. There was no evidence of hepatosplenomegaly or liver cirrhosis. Colonoscopy revealed hemangiomatous involvement in the rectum. There were rectal varices without evidence of active bleeding. Upon venography of the left leg, we also found infiltrative dilated superficial veins in the subcutaneous tissue and aneurysmal dilatation of the deep veins. The patient was finally diagnosed with KTS, and treated with oral iron supplementation only, which has been tolerable to date. Intervention or surgery is not required. When gastrointestinal varices or hemangiomatous mucosal changes are detected in a young patient without definite underlying cause, KTS should be considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21960105     DOI: 10.4166/kjg.2011.58.3.157

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  1 in total

1.  Massive splenomegaly caused by cavernous hemangiomas associated with Klippel-Trenaunay syndrome: report of a case.

Authors:  Takeyuki Misawa; Hiroaki Shiba; Yuki Fujiwara; Yasuro Futagawa; Toru Harada; Masahiro Ikegami; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2013-11-20       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.